A blood test may help identify which patients with colorectal cancer that has spread to the liver are most likely to benefit from chemotherapy after surgery, according to research presented today at ...

There is a constant war going on in your body. Working against you are viruses and cancer cells growing uncontrollably, threatening your tissues and organs. Fighting on your side are immune cells such ...

Inside every cell are lipid molecules that make up cellular membranes, helping organelles communicate and respond to stress.

The Blackstone president and his wife are funding a new Penn institute that uses AI and biomarkers to intercept hereditary cancers at their earliest stages.

Northwestern Medicine scientists have demonstrated that a highly sensitive blood test can detect traces of pancreatic cancer ...

A Chinese research team has developed the world's first blood-based diagnostic kit that can tell whether lung nodules are benign or cancerous, including very small nodules that are often difficult to ...

Lauren writes about healthcare AI data interoperability, the science behind public health recommendations, and pharmaceutical advances in the rare disease space. In a rare move, nonprofit organization ...

If you can’t prevent cancer, the best chances of treating or surviving it may come down to finding a tumor early when it hasn’t yet spread. A new test called Cancerguard offers to screen for more than ...

At least 12 of my colleagues boarded planes to the American Society of Clinical Oncology conference in Chicago last week to hear Charles Swanton of the Francis Crick Institute in London share results ...

The American Cancer Society (ACS) updated its guidelines Wednesday to include two new screening options for colorectal cancer, including a first-ever blood test. The ACS already recommends that adults ...

For the first time, a blood test has been added to the list of the American Cancer Society’s recommended screenings for colorectal cancer. It’s not meant to replace colonoscopies, aiming instead at ...

Early detection remains one of the most critical determinants of cancer outcomes. Despite significant advances in imaging and systemic therapies, a substantial proportion of patients diagnosed with ...